Fig. 5From: Development and verification of a 7-lncRNA prognostic model based on tumor immunity for patients with ovarian cancerConstruction of the immune-related lncRNA risk model in TCGA cohort. A LASSO coefficient profiles of the common genes. B Cross-validation for tuning parameter screening in the LASSO regression model. C, D Distribution of risk score, survival time and survival status. E Heatmap of the 7 lncRNA expression pattern in clinicopathologic characteristics and risk score in the TCGA database. F Correlation between the 7 lncRNAs. G Survival analysis for different risk groups in the combined TCGA-OC patients. H Time-dependent ROC curve analysis of the risk modelBack to article page